x
Breaking News
More () »

Experimental toothpaste could help people with a peanut allergy. It's being tested in Buffalo.

The company has entered human trials with the support of Circuit Clinical – a startup in Buffalo that helps companies administer clinical trials.
Credit: cristovao31 - stock.adobe.com
Closeup of a toothbrush and toothpaste on blurred background

BUFFALO, N.Y. — A New York City-based biotech company is getting a boost in Buffalo as it explores the potential of its lead product – a toothpaste that helps peanut allergy sufferers.

Intrommune Therapeutics' toothpaste contains small amounts of allergens, helping patients build up a tolerance toward the goal of less severe reactions if they are exposed to peanuts.

The company has entered human trials with the support of Circuit Clinical – a startup in Buffalo that helps companies administer clinical trials –  and has enrolled about eight patients toward its overall goal of 40.

For more on this story, please visit the Buffalo Business First website.